Novavax Inc.’s shares plunged, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business.The stock fell 28.3% to a 3-year low of US$6.64 around 10:30 a.m. ET, while its Frankfurt-listed shares slumped more than 27%.
Novavax Inc.’s shares plunged, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business
